TRCT
CME icon

Tower Research Capital (TRC)’s CME Group CME Stock Holding History

Tower Research Capital (TRC)’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Sell
11,346
-1,928
-15% -$573K 0.09% 231
2025
Q4 		$3.62M Buy
13,274
+2,509
+23% +$682K 0.09% 201
2025
Q3 		$2.91M Buy
10,765
+2,119
+25% +$577K 0.08% 213
2025
Q2 		$2.38M Sell
8,646
-5,540
-39% -$1.51M 0.06% 273
2025
Q1 		$3.76M Sell
14,186
-8,973
-39% -$2.21M 0.11% 147
2024
Q4 		$5.38M Buy
23,159
+12,815
+124% +$2.95M 0.11% 152
2024
Q3 		$2.28M Sell
10,344
-10,280
-50% -$2.13M 0.06% 248
2024
Q2 		$4.05M Buy
20,624
+5,040
+32% +$1.04M 0.07% 247
2024
Q1 		$3.36M Sell
15,584
-37,780
-71% -$7.94M 0.08% 181
2023
Q4 		$11.2M Buy
53,364
+35,439
+198% +$7.56M 0.14% 122
2023
Q3 		$3.59M Sell
17,925
-1,602
-8% -$318K 0.11% 161
2023
Q2 		$3.62M Buy
19,527
+9,445
+94% +$1.75M 0.12% 113
2023
Q1 		$1.93M Buy
10,082
+2,244
+29% +$406K 0.06% 210
2022
Q4 		$1.32M Sell
7,838
-33,582
-81% -$5.84M 0.05% 284
2022
Q3 		$7.34M Buy
41,420
+17,754
+75% +$3.51M 0.12% 142
2022
Q2 		$4.84M Sell
23,666
-36,753
-61% -$7.79M 0.11% 149
2022
Q1 		$14.4M Buy
60,419
+29,988
+99% +$7.04M 0.14% 129
2021
Q4 		$6.95M Buy
30,431
+21,736
+250% +$4.78M 0.12% 138
2021
Q3 		$1.68M Sell
8,695
-5,617
-39% -$1.14M 0.04% 311
2021
Q2 		$3.04M Sell
14,312
-23,608
-62% -$4.98M 0.08% 186
2021
Q1 		$7.75M Buy
37,920
+22,463
+145% +$4.42M 0.13% 136
2020
Q4 		$2.81M Buy
15,457
+4,081
+36% +$694K 0.09% 155
2020
Q3 		$1.9M Buy
11,376
+5,790
+104% +$975K 0.02% 432
2020
Q2 		$908K Buy
5,586
+2,285
+69% +$410K 0.04% 586
2020
Q1 		$570K Buy
3,301
+2,173
+193% +$433K 0.03% 388
2019
Q4 		$226K Sell
1,128
-2,390
-68% -$490K 0.02% 537
2019
Q3 		$744K Buy
3,518
+3,345
+1,934% +$699K 0.05% 396
2019
Q2 		$34K Sell
173
-7,040
-98% -$1.3M ﹤0.01% 1822
2019
Q1 		$1.19M Sell
7,213
-1,057
-13% -$187K 0.07% 223
2018
Q4 		$1.56M Buy
8,270
+3,715
+82% +$686K 0.11% 178
2018
Q3 		$775K Sell
4,555
-8,487
-65% -$1.43M 0.06% 296
2018
Q2 		$2.14M Buy
+13,042
New +$2.13M 0.12% 157
2018
Q1 		– Sell
-5,546
Closed -$810K – 3319
2017
Q4 		$810K Buy
5,546
+4,542
+452% +$647K 0.1% 198
2017
Q3 		$136K Buy
+1,004
New +$127K 0.01% 1077
2017
Q2 		– Sell
-53
Closed -$6K – 2785
2017
Q1 		$6K Sell
53
-9,513
-99% -$1.14M ﹤0.01% 2078
2016
Q4 		$1.1M Buy
9,566
+9,531
+27,231% +$1.06M 0.12% 185
2016
Q3 		$4K Sell
35
-1,586
-98% -$166K ﹤0.01% 2658
2016
Q2 		$157K Buy
1,621
+1,325
+448% +$125K 0.02% 815
2016
Q1 		$28K Buy
+296
New +$26.9K ﹤0.01% 1110
2015
Q1 		– Sell
-1,452
Closed -$129K – 4448
2014
Q4 		$129K Sell
1,452
-1,282
-47% -$109K 0.01% 475
2014
Q3 		$219K Sell
2,734
-4,026
-60% -$303K 0.02% 495
2014
Q2 		$480K Sell
6,760
-1,215
-15% -$85.5K 0.06% 273
2014
Q1 		$590K Buy
7,975
+7,075
+786% +$534K 0.08% 182
2013
Q4 		$71K Sell
900
-3,469
-79% -$272K 0.01% 1099
2013
Q3 		$323K Buy
+4,369
New +$322K 0.03% 480

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tower Research Capital (TRC)'s CME Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its CME Group (CME) stake by 15% in Q1 2026, selling an estimated $573K and leaving 11,346 shares worth $3.35M. The position accounts for 0.09% of the portfolio, ranked #231.

Tower Research Capital (TRC) first reported a position in CME in Q3 2013 and has held it in 45 quarters since. The position peaked at $14.4M in Q1 2022. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Tower Research Capital (TRC) held 11,346 shares of CME Group worth $3.35M as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,928 CME Group shares in Q1 2026, an estimated $573K.
  • CME Group made up 0.09% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #231 holding.
  • Tower Research Capital (TRC) first reported a position in CME Group in Q3 2013 and has held it in 45 quarters since.
  • Tower Research Capital (TRC)'s CME Group position peaked at $14.4M in Q1 2022.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.